InsideArbitrage Event Driven Monitor – October 10, 2025
Merger Arbitrage
- AKRO: The acquisition of Akero Therapeutics, Inc. (AKRO) by Novo Nordisk A/S (NVO) for a closing value of $4.7 billion. Akero shareholders will receive $54 per share in cash at closing and a non-transferable Contingent Value Right (CVR). The cash portion of $54 per share represents a premium of 16.15% from the stock’s last close. Each CVR will entitle its holder to receive a cash payment of $6 per share upon full U.S. regulatory approval of efruxifermin (EFX) for treatment of compensated cirrhosis due to MASH by June 30, 2031. (Press Release)
- MTAL: MAC Copper (MTAL) announced that the Royal Court of Jersey made orders sanctioning the proposed acquisition of MAC by Harmony Gold (HMY).
- WNS: WNS (WNS) announced that the company’s application to be acquired by Capgemini has been sanctioned by the Royal Court of Jersey. The company now expects that the transaction will close on October 17, 2025.
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.